Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)

Clinical trial NCT02880943 · UNKNOWN

Trial details

NCT number: NCT02880943
Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear-cell Metastatic Renal Cell Carcinoma Bone Metastases

Start date: 2016-10-01
Primary completion: 2020-10-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.